Novel use of pyrolo-pyridine derivatives for preventing or treating cancer
KR20200127888A
Oral pharmaceutical compositions in the form of solid formulation comprising ibrutinib or a pharmaceutically acceptable salt thereof and processes for preparing the same
KR20200111644A
Heteroaryl derivatives, preparation method the same, and pharmaceutical composition comprising the same as an active ingredient
WO2020185044A1
Heteroaryl derivatives and pharmaceutical composition comprising same as active ingredient
WO2020149715A1
Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related disease
WO2020149553A1
Aryl or heteroaryl derivative, and pharmaceutical composition comprising same as active ingredient for treatment of kinase-related disease
KR20190084490A
Pharmaceutical composition for preventing or treating cancer comprising compounds penetrating blood-brain barrier
